Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Middle East Pharmaceutical Industries Company SJSC
Common Shares Outstanding
Middle East Pharmaceutical Industries Company SJSC
Common Shares Outstanding Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
M
|
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
|
Common Shares Outstanding
ď·Ľ20m
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
SAU:2070
|
Common Shares Outstanding
ď·Ľ119.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
J
|
Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015
|
Common Shares Outstanding
ď·Ľ70m
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Middle East Pharmaceutical Industries Company SJSC
Glance View
Middle East Pharmaceutical Industries Company SJSC is a SA-based company operating in Pharmaceuticals industry. The company is headquartered in Riyadh, Riyadh and currently employs 335 full-time employees. The company went IPO on 2024-02-27. Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The firm develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
See Also
What is Middle East Pharmaceutical Industries Company SJSC's Common Shares Outstanding?
Common Shares Outstanding
20m
SAR
Based on the financial report for Dec 31, 2023, Middle East Pharmaceutical Industries Company SJSC's Common Shares Outstanding amounts to 20m SAR.
What is Middle East Pharmaceutical Industries Company SJSC's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 3Y
0%
Over the last year, the Common Shares Outstanding growth was 0%.